Alternatives

Hedge fund capabilities

$2.9bn

Assets in hedge fund capabilities*

27+

Years of combined technology and industry experience across senior team members*

22

Investment professionals across technology and healthcare long/short capabilities*

*As of 31 May 2025.

Specialist technology and healthcare investor

Columbia Threadneedle Investments’ technology and healthcare capabilities are managed by Seligman Investments1, a Silicon Valley-based technology investment team. As of 31 May 2025 the team manages $20.5bn in hedge funds and long-only technology and healthcare capabilities.

Our team operates in a boutique-style environment, structured for comprehensive industry coverage driven by individual team members’ broad experience within a particular industry or sub-industry. Our team of analysts provides breadth and depth across semiconductors, computing, data storage, networking, software, internet, media, telecommunications, biotechnology, pharmaceuticals and medical technology.

Part of our multi-faceted Alternatives business

Seligman Investments’ hedge fund capability forms part of Columbia Threadneedle Investments’ global $68.0bn2 Alternatives business.

1Seligman Investments is an offering brand of Columbia Management Investment Advisers, LLC (“CMIA”). CMIA capabilities are promoted by Threadneedle Investments Singapore (Pte) Limited in Singapore and Australia, and by Threadneedle Portfolio Services Hong Kong Limited in Hong Kong.

2As of 30 June 2025.

What sets us apart?

Depth of knowledge

Our deep and tenured analyst team with specialised knowledge covers all key sub-sectors in technology and healthcare. It is led by a portfolio manager with over 30 years of investment experience who is recognised as one of the most successful technology investment professionals in the US.

Results

The broad and comprehensive research coverage by our analysts and the collaborative, team approach to idea generation and decision making are instrumental to the success of our portfolio management process and track record.

Commitment

The team has invested a significant percentage of its liquid net worth, deeply aligning its interests with those of our investors and ensuring intense discipline and focus on the management of downside risk.

Global infrastructure

The Seligman Investment team has an entrepreneurial Silicon Valley culture and benefits from the corporate access, trading, operational, and compliance depth that comes from the scale of Columbia Threadneedle Investments and its parent company, a Fortune 500 Company*, Ameriprise Financial.


*Fortune and Fortune 500 are registered trademarks of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, Ameriprise Financial, Inc.

“We manage downside risk of investors’ capital by exercising due diligence in scrutinising each company’s technology claims, business models, end markets and competition.”

Paul Wick
Chief Investment Officer, Seligman Investments

Pipette being squeezed over a jar

Our investment focus

Technology

Technology is the largest industry sector in the world and the fastest growing for three decades.* Technology products and services are complex, and our analysts’ backgrounds enable them to dive deep into the underlying components, software, silicon, intellectual property, and other considerations. We adopt a value-tech approach; akin to private equity in the public markets that avoids the mindset of growth at all costs.

Our research process further benefits from the team’s extensive network across the Silicon Valley ecosystem of CEOs, executives, entrepreneurs, engineers, scientists, bankers, lenders, and investors across the technology life-cycle from seed to distress.

Healthcare

Our experienced, multi-faceted team benefits from technical scientific and clinical training, as well as actual healthcare operating experience including M&A, product launch and extensive healthcare industry network. The team’s investment approach is built on tools and frameworks enabling repeatability and objectivity and allows for deep understanding of healthcare and strategic identification of the most innovative medical/scientific companies.

The team is well-resourced and has holistic coverage / sub-sector expertise. To uncover investment opportunities, the team conducts ongoing analysis of key themes, such as evolutions in science, medicine, product launches, reimbursement, regulatory and policy changes.

* Source: FactSet Research Systems, as of 31 December 2024.

Our process

Constant ongoing activities to uncover new investment opportunities Idea Generation Qualitative and quantitative assessment to determine viability and fit Analysis Identification of portfolio fit and position sizing Execution Ongoing review of individual positions and overall portfolio structure / risk Monitoring
Constant ongoing activities to uncover new investment opportunities Idea Generation Qualitative and quantitative assessment to determine viability and fit Analysis Identification of portfolio fit and position sizing Execution Ongoing review of individual positions and overall portfolio structure / risk Monitoring
Icon of a lightbulb

Idea Generation

Constant ongoing activities to uncover new investment opportunities

Icon of a magnifying glass over a graph

Analysis

Qualitative and quantitative assessment to determine viability and fit

Icon of a large cog and a small cog

Execution

Identification of portfolio fit and position sizing
Icon of a computer screen with a graph

Monitoring

Ongoing review of individual positions and overall portfolio structure / risk

Our hedge fund capabilities leadership team

Seligman Investments’ team is supported by Columbia Threadneedle Investments’ vast infrastructure across trading, compliance, operations, additional research, risk management, marketing and sales functions. This allocation of responsibilities allows the investment team to focus all of its attention on proactive fund investment and management as well as investor relations, in an effort to continue to deliver returns and a high-quality service for investors.

Insights

How artificial intelligence is reshaping financial services

AI is helping enhance efficiency, reduce costs and improve decision-making.

Navigating market volatility amid US tariffs and policy uncertainty

Amid uncertainty in equities and credit markets, we remain focused on long-term investment fundamentals and building portfolios to weather the storm and deliver for clients.

CT Net Zero Transition Low Duration Credit

A short-dated global credit strategy with a formal commitment to net zero by 2050.

CT UK Social Bond

Woven for social impact and long-term returns.

CT Global Social Bond

A fund built to make a positive impact. Both socially and financially.

Insights

4 4月 2025

David Egan

Senior Research Analyst

Dick Manuel

Senior Analyst, Equity Research

How artificial intelligence is reshaping financial services

AI is helping enhance efficiency, reduce costs and improve decision-making.
19 3月 2025

William Davies

Global Chief Investment Officer

Navigating market volatility amid US tariffs and policy uncertainty

Amid uncertainty in equities and credit markets, we remain focused on long-term investment fundamentals and building portfolios to weather the storm and deliver for clients.

Important Information

For use by professional clients and/or equivalent investor types in your jurisdiction (not to be used with or passed on to retail clients). For marketing purposes. The above information is intended for informational purposes only and should not be considered representative of any particular investment. This should not be considered an offer or solicitation to buy or sell any securities or other financial instruments, or to provide investment advice or services.

Investing involves risk including the risk of loss of principal. Your capital is at risk. Market risk may affect a single issuer, sector of the economy, industry or the market as a whole. The value of investments is not guaranteed, and therefore an investor may not get back the amount invested. International investing involves certain risks and volatility due to potential political, economic or currency fluctuations and different financial and accounting standards. Real estate investing involves risks, including, without limitation: (i) actual operating results; (ii) interest rates; (iii) availability and costs of financing; (iv) economic and market conditions; (v) date of expected exit; (vi) increases in costs of materials or services beyond projections; (vii) force majeure events (e.g., terrorist attacks, extreme weather conditions, earthquakes, war); (viii) supply/demand imbalances; (ix) currency fluctuations; (x) litigation and disputes relating to investments with joint venture partners or third parties; (xi) changes in zoning and other laws; (xii) inability to obtain necessary licenses and permits; (xiii) competition; and (xiv) changes in tax law and tax treatment and disallowance of tax positions. The value of directly-held property reflects the opinion of valuers and is reviewed periodically. These assets can also be illiquid and significant or persistent redemptions may require the manager to sell properties at a lower market value adversely affecting the value of your investment.

The views expressed are as of the date given, may change as market or other conditions change and may differ from views expressed by other Columbia Threadneedle Investments (Columbia Threadneedle) associates or affiliates. Actual investments or investment decisions made by Columbia Threadneedle and its affiliates, whether for its own account or on behalf of clients, may not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not take into consideration individual investor circumstances. Investment decisions should always be made based on an investor’s specific financial needs, objectives, goals, time horizon and risk tolerance. Asset classes described may not be appropriate for all investors. Past performance does not guarantee future results, and no forecast should be considered a guarantee either. The information presented above has not been reviewed by any regulatory authority.

In Hong Kong: Issued by Threadneedle Portfolio Services Hong Kong Limited 天利投資管理香港有限公司. Unit 3004, Two Exchange Square, 8 Connaught Place, Hong Kong, which is licensed by the Securities and Futures Commission (“SFC”) to conduct Type 1 regulated activities (CE:AQA779). Registered in Hong Kong under the Companies Ordinance (Chapter 622), No. 1173058.

In Singapore: Issued by Threadneedle Investments Singapore (Pte.) Limited, 3 Killiney Road, #07-07, Winsland House 1, Singapore 239519, which is regulated in Singapore by the Monetary Authority of Singapore under the Securities and Futures Act (Chapter 289). Registration number: 201101559W. This advertisement has not been reviewed by the Monetary Authority of Singapore.

In Australia: Issued by Threadneedle Investments Singapore (Pte.) Limited [“TIS”], ARBN 600 027 414. TIS is exempt from the requirement to hold an Australian financial services licence under the Corporations Act 2001 (Cth) and relies on Class Order 03/1102 in respect of the financial services it provides to wholesale clients in Australia. The information presented above should only be distributed in Australia to “wholesale clients” as defined in Section 761G of the Corporations Act. TIS is regulated in Singapore (Registration number: 201101559W) by the Monetary Authority of Singapore under the Securities and Futures Act (Chapter 289), which differ from Australian laws.

© Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies.